Domestic High-End Phacoemulsification System Achieves Major Breakthrough: YINI® Enables Precision Treatment for Complex Cataracts

China, Shanghai —— On July 25, MicroPort NeuroTech (Shanghai) Co., Ltd. (hereinafter referred to as "MicroPort^®"Vision God") Developed and Produced by INI^®（YINI^®) Phacoemulsification System for cataract surgery has been approved for marketing by the National Medical Products Administration (NMPA) of China (Registration Certificate No. 20253161464).

As a domestically-produced high-end floor-standing phacoemulsification device, Yini^®In key performance indicators such as nuclear fragmentation efficiency and fluid flow control, it has reached an internationally leading level, providing high-quality solutions produced in China for clinical cataract treatment, especially for the surgical needs of complex cases.

In terms of energy control, Yini^®The core ultrasound energy system adopts a six-piece piezoelectric ceramic driver, combined with a bell-mouth design at the needle tip, enhancing the gripping area of the nucleus and improving stability during fragmentation. It is suitable for a wider range of complex indications. In terms of fluid management, it is equipped with high-precision non-contact sensors that can monitor intraocular pressure and suction pressure in real time, ensuring stable intraoperative eye pressure. The high-performance precision peristaltic pump, along with the tapered roller design and rigid fluid box channels, effectively mitigates pressure "surges" when the phacoemulsification needle becomes clogged. The elastic silicone membrane structure closely adheres to the pump head, maintaining a stable negative pressure above 650mmHg, ensuring continuous and powerful suction.

As the "gold standard" for current cataract treatment, phacoemulsification surgery has extremely high requirements for equipment in two aspects: energy delivery (determining nucleus fragmentation efficiency) and fluidic management (ensuring surgical safety). In the past, Chinese-produced phaco machines were mostly portable, struggling to fully meet all clinical needs; in contrast, floor-standing phacoemulsification systems with stronger vacuum capabilities, more comprehensive intraocular pressure monitoring systems, and more efficient ultrasound energy delivery have long been dominated by imported brands in the market.

Picturesque^®The floor-standing ultrasonic emulsifier took five years to develop, integrating multiple independent innovative technologies,Achieved a breakthrough in the high-end performance field of ophthalmic medical equipment produced in China.。

In Yini^®In the research and development process, minimally invasive^®Visual God also continuously accumulates key technologies, having built multiple core technology platforms covering ultrasound, fluid, materials, optics, and more, providing strong support for existing and future product pipelines, and will bring more high-quality, accessible domestically-produced medical solutions to patients with eye diseases.